BamSEC and AlphaSense Join Forces
Learn More

KalVista Pharmaceuticals Inc.

NASDAQ: KALV    
Share price (12/31/24): $8.47    
Market cap (12/31/24): $419 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
Other Revised 09/19/24 KalVista Pharmaceuticals, Inc. Presents at 2024 Cantor Fitzgerald Global Healthcare Conference, Sep-19-2024 10:20 AM 09/19/24 Other Revised 02/13/24 KalVista Pharmaceuticals, Inc. - Special Call 02/13/24
CY 2022
Other Revised 07/20/22 KalVista Pharmaceuticals, Inc. Presents at H.C. Wainwright 1st Annual Hereditary Angioedema (HAE) Conference, Jul-20-2022 07/20/22 Other Revised 04/13/22 KalVista Pharmaceuticals, Inc. Presents at Needham 21st Annual Healthcare Conference, Apr-13-2022 03:00 PM 04/13/22 Other Revised 02/16/22 KalVista Pharmaceuticals, Inc. Presents at 11th SVB Leerink Annual Global Healthcare Conference 2022, Feb-16-2022 09:20 AM 02/16/22
CY 2021
Other Revised 09/27/21 KalVista Pharmaceuticals, Inc. Presents at Cantor Global Healthcare 2021 Conference, Sep-27-2021 08:40 AM 09/27/21 Other Revised 02/09/21 KalVista Pharmaceuticals, Inc. - Special Call 02/09/21
CY 2019
Other Revised 11/21/19 KalVista Pharmaceuticals, Inc. Presents at Jefferies 2019 London Healthcare Conference, Nov-21-2019 08:00 AM 11/21/19 Other Revised 11/19/19 KalVista Pharmaceuticals, Inc. Presents at Stifel 2019 Healthcare Conference, Nov-19-2019 08:00 AM 11/19/19